XML 68 R55.htm IDEA: XBRL DOCUMENT v3.8.0.1
Capital Transactions - Stock Compensation (Details) - USD ($)
12 Months Ended
May 04, 2010
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Performance period   90 days        
Compensation expenses            
Stock based compensation expense   $ 10,580,000 $ 7,568,000 $ 5,368,000    
Director            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Granted (in shares)   22,617 42,624 36,950    
Granted (in dollars per share)   $ 35.81 $ 14.78 $ 14.05    
Number of shares            
Granted (in shares)   22,617 42,624 36,950    
Weighted Average Grant-Date Fair Value            
Granted (in dollars per share)   $ 35.81 $ 14.78 $ 14.05    
Maximum            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Award percentage   200.00% 150.00%      
Minimum            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Award percentage   0.00% 0.00%      
Stock options and restricted stock            
Compensation expenses            
Total unrecognized compensation cost         $ 10,600,000  
Unrecognized compensation cost recognized over a weighted average period (in years)   1 year 8 months 12 days        
Employee stock option            
Share-Based Compensation            
Options outstanding (in shares)   819,981 1,064,429 2,888,074 458,103 819,981
Compensation expenses            
Period from grant date after which stock options become exercisable, minimum (in months)   6 months        
Period from grant date within which incentive stock options are exercisable, maximum (in years)   7 years        
Number of Options            
Outstanding at the beginning of the period (in shares)   819,981 1,064,429 2,888,074    
Granted (in shares)     206,021 267,433    
Exercised (in shares)   (356,209) (351,296) (544,917)    
Cancelled (in shares)   (5,669) (99,173) (1,546,161)    
Outstanding at the end of the period (in shares)   458,103 819,981 1,064,429    
Exercisable (in shares)         254,192 263,851
Weighted Average Exercise Price            
Outstanding at the beginning of the period (in dollars per share)   $ 13.58 $ 13.64 $ 16.46    
Granted (in dollars per share)     14.90 13.63    
Exercised (in dollars per share)   13.36 14.17 14.68    
Cancelled (in dollars per share)   14.33 14.90 18.53    
Outstanding at the end of the period (in dollars per share)   $ 13.73 $ 13.58 $ 13.64    
Exercisable (in dollars per share)         $ 13.17 $ 13.76
Weighted Average Remaining Contractual Term            
Outstanding, Weighted Average Remaining Contractual Term (in years)   4 years 4 years 4 months 24 days      
Exercisable, Weighted Average Remaining Contractual Term (in years)   3 years 4 months 24 days 2 years 9 months 18 days      
Aggregate Intrinsic Value            
Average intrinsic value of shares outstanding         $ 18,034,100 $ 18,756,900
Average intrinsic value of shares exercisable         $ 10,150,800 $ 5,985,500
Total intrinsic value of options exercised   $ 9,940,000 $ 4,250,000 $ 1,800,000    
Non-vested stock options            
Non-vested shares at beginning of year (in shares)   556,130        
Granted (in shares)     206,021 267,433    
Vested (in shares)   (346,550)        
Cancelled (in shares)   (5,669)        
Non-vested shares at end of year (in shares)   203,911 556,130      
Weighted Average Grant-Date Fair Value            
Non-vested shares at beginning of year (in dollars per share)   $ 4.86        
Vested (in dollars per share)   4.67        
Cancelled (in dollars per share)   5.14        
Non-vested shares at end of year (in dollars per share)   $ 5.17 $ 4.86      
Performance share units            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Granted (in shares)   119,315 183,577 222,583    
Granted (in dollars per share)   $ 35.81 $ 14.89 $ 13.61    
Performance period   3 years        
Number of shares            
Nonvested shares at the beginning of the period (in shares)   363,993 202,829      
Granted (in shares)   119,315 183,577 222,583    
Cancelled (in shares)   (14,732) (22,413) (19,754)    
Nonvested shares at the end of the period (in shares)   468,576 363,993 202,829    
Weighted Average Grant-Date Fair Value            
Nonvested shares at the beginning of the period (in dollars per share)   $ 14.23 $ 13.62      
Granted (in dollars per share)   35.81 14.89 $ 13.61    
Cancelled (in dollars per share)   15.00 14.16 13.51    
Nonvested shares at the end of the period (in dollars per share)   $ 19.70 $ 14.23 $ 13.62    
Restricted stock units            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Granted (in shares)   160,137 384,148 408,163    
Granted (in dollars per share)   $ 35.81 $ 14.81 $ 13.57    
Number of shares            
Nonvested shares at the beginning of the period (in shares)   926,931 809,299 723,176    
Granted (in shares)   160,137 384,148 408,163    
Vested (in shares)   (230,903) (215,146) (215,856)    
Cancelled (in shares)   (40,575) (51,370) (106,184)    
Nonvested shares at the end of the period (in shares)   815,590 926,931 809,299    
Weighted Average Grant-Date Fair Value            
Nonvested shares at the beginning of the period (in dollars per share)   $ 13.65 $ 13.13 $ 12.70    
Granted (in dollars per share)   35.81 14.81 13.57    
Vested (in dollars per share)   12.01 13.29 13.06    
Cancelled (in dollars per share)   15.78 13.72 13.52    
Nonvested shares at the end of the period (in dollars per share)   $ 18.35 $ 13.65 $ 13.13    
Long Term Incentive Plan 2010            
Share-Based Compensation            
Number of shares authorized 5,150,000          
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Vesting period     3 years 3 years    
Long Term Incentive Plan 2010 | Employee stock option            
Share-Based Compensation            
Minimum incentive stock option exercise price, expressed as a percentage of common stock grant date market value 100.00%          
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Expected annual dividend rate (as a percent)     1.08% 1.18%    
Risk-free interest rate (as a percent)     1.15% 1.62%    
Average expected life (years)     5 years 8 months 12 days 5 years 8 months 12 days    
Expected volatility of common stock (as a percent)     0.412% 0.401%    
Forfeiture rate (as a percent)     0.00% 0.00%    
Weighted average fair value of option grants     $ 5.27 $ 4.75    
Number of Options            
Granted (in shares)     206,021 267,433    
Non-vested stock options            
Granted (in shares)     206,021 267,433    
Weighted Average Grant-Date Fair Value            
Granted (in dollars per share)     $ 5.27 $ 4.75    
Long Term Incentive Plan 2010 | Restricted stock units            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Vesting period   3 years        
Granted (in dollars per share)   $ 35.81        
Weighted Average Grant-Date Fair Value            
Granted (in dollars per share)   $ 35.81        
Long Term Incentive Plan 2010 | Restricted stock units | Director            
Assumptions used to determine value of the shares purchased under the stock purchase plan using Black-Scholes option pricing model            
Granted (in shares)   160,137        
Number of shares            
Granted (in shares)   160,137